Minnesota FOIA #P010028801

Minnesota Partnership for Biotechnology – Novel Implementation of Spatiotemporal Mapping and Electroporation for theT...

On March 26, 2022, the Twin Cities government awarded Mayo Clinic a contract valued at $447,182 for research related to the Minnesota Partnership for Biotechnology, specifically focusing on novel implementation of spatiotemporal mapping and electroporation for the treatment of persistent atrial fibrillation. The award was a single-transaction purchase, with Mayo Clinic as the recipient, located in Minneapolis, Minnesota. The contract involves advanced biotechnological equipment or services, with Mayo Clinic identified as the vendor. The procurement was managed by the Twin Cities government, a local government entity. The award emphasizes innovative medical research and treatment development. No specific contract period is indicated, but the award appears to be a one-time purchase.

Description

Minnesota Partnership for Biotechnology – Novel Implementation of Spatiotemporal Mapping and Electroporation for theTreatment of Persistent Atrial Fibrillation